AMGN — Amgen

Biotechnology · Health Care

Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and markets human therapeutic drugs. It operates through its Human Therapeutics segment.

Industry Peers

Sector Peers

Key Facts

StatusActive
SectorHealth Care
IndustryBiotechnology
Joined1992-01-02
Tenure34 yrs

S&P 500 Timeline

1992-01-02Joined S&P 500

Institutional Holdings (13F)

3,124 institutions hold AMGN, totaling 552.5M shares ($185.3B) · As of 2026Q1

RankInstitutionSharesValue
1VANGUARD CAPITAL MANAGEMENT LLC70.0M$24.6B
2BlackRock, Inc.47.1M$16.6B
3MORGAN STANLEY47.5M$15.2B
4STATE STREET CORP30.5M$10.7B
5Capital World Investors29.3M$10.3B
6BARCLAYS PLC28.3M$8.2B
7GEODE CAPITAL MANAGEMENT, LLC15.4M$5.4B
8VANGUARD PORTFOLIO MANAGEMENT LLC14.6M$5.1B
9CHARLES SCHWAB INVESTMENT MANAGEMENT INC12.8M$4.5B
10PRIMECAP MANAGEMENT CO/CA/8.9M$3.1B

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10